XWAR
ADV
Market cap2mUSD
Oct 07, Last price
0.60PLN
1D
-0.66%
1Q
39.53%
Jan 2017
-97.85%
IPO
-97.84%
Name
Adiuvo Investments SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Adiuvo Investments S.A. operates as a venture capital firm, deploying capital across the entire spectrum of business development, from initial incubation and seed funding to supporting early-stage, startup, and growth-phase companies. Its primary investment focus lies in the medical devices, digital health, and nutraceuticals sectors, specifically targeting opportunities within Poland. The firm typically commits up to €3 million (approximately $3.35 million) per venture, with an intended holding period of three to five years. All investments are made directly from Adiuvo's own balance sheet. Established in 2013, the company maintains its headquarters in Warsaw, Poland.
Related entities
Subsidiaries
ADIUVO MANAGEMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Key people
Marek Orlowski
Chairman of the Management Board · since 2014
Independent Deputy Chairman Supervisory of the Board · since 2021
Member of the Management Board · since 2014
Independent Member of the Supervisory Board · since 2021
Wojciech Bablok
Member of the Supervisory Board · since 2024
Przemyslaw Cipyk
Independent Member of the Supervisory Board · since 2021
Emil Tomaszewski
Member of the Supervisory Board · since 2025
Boguslaw Ulijasz
Independent Member of the Supervisory Board · since 2022
Headquarters & legal address
WARSZAWA SZARA 10
WARSZAWA, 14 00-420
PL
WARSZAWA, 14 00-420
PL
Previous name
ADIUVO INVESTMENTS SPÓŁKA AKCYJNA
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||